Current Gene Therapy
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 6
Author(s): Alexis M. Kalergis
Affiliation:
Export Options
About this article
Cite this article as:
Kalergis M. Alexis, Meet Our Editorial Board Member, Current Gene Therapy 2016; 16 (6) . https://dx.doi.org/10.2174/156652321606170315093959
DOI https://dx.doi.org/10.2174/156652321606170315093959 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chinese Character Voice Processing of the Bilateral Inferior Parietal Lobule of Literate Compared with Illiterate Subjects: An fMRI Study
Neuroscience and Biomedical Engineering (Discontinued) Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews 5-ht6 Receptors
Current Drug Targets - CNS & Neurological Disorders Potential Drugs and Methods for Preventing or Delaying the Progression of Huntington's Disease
Recent Patents on CNS Drug Discovery (Discontinued) Enzymatic Catalysis in Presence of Cyclodextrins
Current Organic Chemistry Possible Neuroprotective Strategies for Huntingtons Disease
Current Neuropharmacology Novel Therapies for Asthma - Advances and Problems
Current Pharmaceutical Design Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
CNS & Neurological Disorders - Drug Targets GABAB Receptors as Potential Therapeutic Targets
Current Drug Targets - CNS & Neurological Disorders Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
CNS & Neurological Disorders - Drug Targets Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
Mini-Reviews in Medicinal Chemistry Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery A Review of Pharmacological Properties and Toxicological Effects of Adiantum capillus-veneris L.
Current Drug Discovery Technologies Alveolar Bone Mineral Density Measurement using CBCT Images
Neuroscience and Biomedical Engineering (Discontinued) Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
Current Pharmaceutical Design Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Current Drug Targets - CNS & Neurological Disorders